Literature DB >> 20547769

Redox regulation of transglutaminase 2 activity.

Jorunn Stamnaes1, Daniel M Pinkas, Burkhard Fleckenstein, Chaitan Khosla, Ludvig M Sollid.   

Abstract

Transglutaminase 2 (TG2) in the extracellular matrix is largely inactive but is transiently activated upon certain types of inflammation and cell injury. The enzymatic activity of extracellular TG2 thus appears to be tightly regulated. As TG2 is known to be sensitive to changes in the redox environment, inactivation through oxidation presents a plausible mechanism. Using mass spectrometry, we have identified a redox-sensitive cysteine triad consisting of Cys(230), Cys(370), and Cys(371) that is involved in oxidative inactivation of TG2. Within this triad, Cys(370) was found to participate in disulfide bonds with both Cys(230) and its neighbor, Cys(371). Notably, Ca(2+) was found to protect against formation of these disulfide bonds. To investigate the role of each cysteine residue, we created alanine mutants and found that Cys(230) appears to promote oxidation and inactivation of TG2 by facilitating formation of Cys(370)-Cys(371) through formation of the Cys(230)-Cys(370) disulfide bond. Although vicinal disulfide pairs are found in several transglutaminase isoforms, Cys(230) is unique for TG2, suggesting that this residue acts as an isoform-specific redox sensor. Our findings suggest that oxidation is likely to influence the amount of active TG2 present in the extracellular environment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547769      PMCID: PMC2919103          DOI: 10.1074/jbc.M109.097162

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Probability-based protein identification by searching sequence databases using mass spectrometry data.

Authors:  D N Perkins; D J Pappin; D M Creasy; J S Cottrell
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

Review 2.  Transglutaminases: crosslinking enzymes with pleiotropic functions.

Authors:  Laszlo Lorand; Robert M Graham
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

3.  Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.

Authors:  P Mariani; F Carsughi; F Spinozzi; S Romanzetti; G Meier; R Casadio; C M Bergamini
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

4.  Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.

Authors:  T S Lai; A Hausladen; T F Slaughter; J P Eu; J S Stamler; C S Greenberg
Journal:  Biochemistry       Date:  2001-04-24       Impact factor: 3.162

5.  Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity.

Authors:  Shenping Liu; Richard A Cerione; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue.

Authors:  Justin L Piper; Gary M Gray; Chaitan Khosla
Journal:  Biochemistry       Date:  2002-01-08       Impact factor: 3.162

Review 7.  Transglutaminase 2: an enigmatic enzyme with diverse functions.

Authors:  Laszlo Fesus; Mauro Piacentini
Journal:  Trends Biochem Sci       Date:  2002-10       Impact factor: 13.807

8.  Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.

Authors:  Burkhard Fleckenstein; Øyvind Molberg; Shuo-Wang Qiao; Dietmar G Schmid; Florian von der Mülbe; Katja Elgstøen; Günther Jung; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2002-07-01       Impact factor: 5.157

9.  Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.

Authors:  Róbert Király; Eva Csosz; Tibor Kurtán; Sándor Antus; Krisztián Szigeti; Zsófia Simon-Vecsei; Ilma Rita Korponay-Szabó; Zsolt Keresztessy; László Fésüs
Journal:  FEBS J       Date:  2009-10-29       Impact factor: 5.542

10.  Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.

Authors:  L Willemijn Vader; Arnoud de Ru; Yvonne van der Wal; Yvonne M C Kooy; Willemien Benckhuijsen; M Luisa Mearin; Jan Wouter Drijfhout; Peter van Veelen; Frits Koning
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  77 in total

1.  Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2.

Authors:  Laila Dafik; Chaitan Khosla
Journal:  Chem Biol       Date:  2011-01-28

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.

Authors:  Michael C Yi; Arek V Melkonian; James A Ousey; Chaitan Khosla
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

Review 4.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

Review 5.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

6.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

Review 7.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

Review 8.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

9.  Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.

Authors:  Abdullah Akbar; Nicole M R McNeil; Marie R Albert; Viviane Ta; Gautam Adhikary; Karine Bourgeois; Richard L Eckert; Jeffrey W Keillor
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

Review 10.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.